Dyslipidemias: Pathophysiology, evaluation and management
Dyslipidemias: Pathophysiology, evaluation and management
复制标题
DOI：
10.1007/978-1-60761-424-1
复制
发表时间：
2015
期刊：
影响因子：
--
通讯作者：
A. Garg
中科院分区：
文献类型：
--
作者：
A. Garg
血脂异常：病理生理学，评估和管理提供了丰富的一般和详细的指导方针的临床评估和管理的脂质紊乱的成人和儿童。涵盖了通过罕见的血脂紊乱的全方位的常见，这个及时的资源提供了有针对性的，实用的信息，为所有临床医生谁照顾病人血脂异常，包括普通内科医生，儿科和成人内分泌学家，儿科医生，血脂专家，心脏病专家，内科医生和遗传学家。在过去的二十年里，全世界越来越认识到管理血脂异常对于动脉粥样硬化性血管疾病，特别是冠心病的一级和二级预防的重要性。这主要是由于美国国家胆固醇教育计划的成人治疗小组和儿科小组的指南出版。这些准则促使世界各地，特别是欧洲、加拿大、澳大利亚和亚洲提出了类似的建议。这本书由一群著名的国际领先专家开发，提供了最先进的章节，经过同行评审，代表了对该领域的全面评估。文献的主要补充，血脂异常：病理生理学，评估和管理是所有临床医生的黄金标准参考，他们面临着为血脂异常患者提供最佳护理和新机会的挑战。
Dyslipidemias: Pathophysiology, Evaluation and Management provides a wealth of general and detailed guidelines for the clinical evaluation and management of lipid disorders in adults and children. Covering the full range of common through rare lipid disorders, this timely resource offers targeted, practical information for all clinicians who care for patients with dyslipidemias, including general internists, pediatric and adult endocrinologists, pediatricians, lipidologists, cardiologists, internists, and geneticists. For the last twenty years, there has been a growing recognition worldwide of the importance of managing dyslipidemia for the primary and secondary prevention of atherosclerotic vascular disease, especially coronary heart disease. This has been mainly due to the publication of the guidelines of National Cholesterol Education Program’s Adult Treatment Panel and Pediatric Panel from the United States. These guidelines have stimulated generation of similar recommendations from all over the world, particularly Europe, Canada, Australia and Asia. Developed by a renowned group of leading international experts, the book offers state-of-the-art chapters that are peer-reviewed and represent a comprehensive assessment of the field. A major addition to the literature, Dyslipidemias: Pathophysiology, Evaluation and Management is a gold-standard level reference for all clinicians who are challenged to provide the best care and new opportunities for patients with dyslipidemias.